Research output per year
Research output per year
Fingerprint
Dive into the research topics where Francesca Zoratto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Research output
-
Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study
Cortellini, A., Cannita, K., Tiseo, M., Cortinovis, D. L., Aerts, J. G. J. V., Baldessari, C., Giusti, R., Ferrara, M. G., D'Argento, E., Grossi, F., Guida, A., Berardi, R., Morabito, A., Genova, C., Antonuzzo, L., Mazzoni, F., De Toma, A., Signorelli, D., Gelibter, A., Targato, G. & 32 others, , 2021, In: European Journal of Cancer. 148, p. 24-35 12 p.Research output: Contribution to journal › Article › peer-review
-
The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer
Banna, G. L., Cortellini, A., Cortinovis, D. L., Tiseo, M., Aerts, J. G. J. V., Barbieri, F., Giusti, R., Bria, E., Grossi, F., Pizzutilo, P., Berardi, R., Morabito, A., Genova, C., Mazzoni, F., Di Noia, V., Signorelli, D., Gelibter, A., Macerelli, M., Rastelli, F., Chiari, R. & 26 others, , Apr 1 2021, In: ESMO Open. 6, 2, p. 100078 1 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study
Ridolfi, L., De Rosa, F., Petracci, E., Tanda, E. T., Marra, E., Pigozzo, J., Marconcini, R., Guida, M., Cappellini, G. C. A., Gallizzi, G., Occelli, M., Pala, L., Gambale, E., Bersanelli, M., Galdo, G., Cortellini, A., Morgese, F., Zoratto, F., Stucci, L. S., Strippoli, S. & 2 others, , 2020, In: Journal of Geriatric Oncology. 11, 3, p. 515-522 8 p.Research output: Contribution to journal › Article › peer-review
-
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study: Journal of Geriatric Oncology
Ridolfi, L., De Rosa, F., Petracci, E., Tanda, E. T., Marra, E., Pigozzo, J., Marconcini, R., Guida, M., Cappellini, G. C. A., Gallizzi, G., Occelli, M., Pala, L., Gambale, E., Bersanelli, M., Galdo, G., Cortellini, A., Morgese, F., Zoratto, F., Stucci, L. S., Strippoli, S. & 2 others, , 2020, In: J. Geriatr. Oncol.. 11, 3, p. 515-522 8 p.Research output: Contribution to journal › Article › peer-review
-
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study: Journal of Geriatric Oncology
Ridolfi, L., De Rosa, F., Petracci, E., Tanda, E. T., Marra, E., Pigozzo, J., Marconcini, R., Guida, M., Cappellini, G. C. A., Gallizzi, G., Occelli, M., Pala, L., Gambale, E., Bersanelli, M., Galdo, G., Cortellini, A., Morgese, F., Zoratto, F., Stucci, L. S., Strippoli, S. & 2 others, , 2020, In: J. Geriatr. Oncol.. 11, 3, p. 515-522 8 p.Research output: Contribution to journal › Article › peer-review